raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:98851

Mast cell leukemia

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A very rare malignant systemic mastocytosis (SM) characterized by a huge infiltration of bone marrow, and often of blood, by abnormal mast cells (MC) which frequently manifests with organ dysfunction (liver, spleen, peritoneum, bones, and marrow).

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMast cell leukemia
frLeucémie à mastocytesLeucémie mastocytaire
deMastzell-Leukämie
esLeucemia mastocitaria
itLeucemia mastocitaria
nlMestcelleukemie
ptLeucemia de mastócitos
plBiałaczka mastocytowa
csLeukémie z žírných buněk
ukМастоцитарна лейкемія
zh肥大细胞白血病
trMast hücreli lösemi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C94.3Especificvalidated
ICD-112A21.00Especificvalidated
MONDO0020334Evalidated
MeSHD007946Evalidated
UMLSC0023461Evalidated
MedDRA10056450Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (2):

Codes that Orphanet moved or referred to this one:

4

Genes

0 direct · 2 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
KITORPHA:566393Acute mast cell leukemiaDisease-causing germline mutation(s) inAssessedHGNC:6342ENSG000001574041649204q12KIT proto-oncogene, receptor tyrosine kinase25729733[PMID]_22324351[PMID]
KITORPHA:566396Chronic mast cell leukemiaDisease-causing germline mutation(s) inAssessedHGNC:6342ENSG000001574041649204q12KIT proto-oncogene, receptor tyrosine kinase25729733[PMID]_22324351[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—EuropeClass onlyNot yet validatedORPHANET
Annual incidence<1 / 1 000 000—EuropeClass onlyValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card